Federal health officials are tracking an extensively drug-resistant (XDR) Salmonella outbreak tied to moringa leaf powder dietary supplements that has now reached 119 confirmed cases spanning 36 states, according to data published May 27, 2026 by the Centers for Disease Control and Prevention.
Of the 109 cases for which hospitalization data are available, 32 people — roughly 29% — required inpatient care. No deaths have been reported.
The designation “extensively drug-resistant” means the Salmonella strains involved do not respond to the first-line antibiotics physicians typically prescribe for these infections, nor to most alternative treatments. Genomic analysis has predicted resistance across multiple drug classes, limiting clinicians’ options and elevating the public-health stakes of even mild-seeming infections.
The CDC and FDA originally opened the investigation in early 2026, then declared it over in March. The discovery of 22 new illnesses across four states prompted officials to reopen the probe in May. The current tally of 119 cases incorporates that expanded cluster.
Traceback evidence has implicated moringa leaf powder used across multiple supplement brands. Recalled products include TNVitamins Ultra Potent Complete Green Superfood Moringa capsules and Doctor’s Pride Complete Green Superfood Ultra Potent Moringa capsules, both distributed by Total Nutrition Inc., as well as Why Not Natural Pure Organic Moringa Green Superfood capsules.
The FDA advises consumers to check their supplement cabinets and discard any recalled products. The investigation remains ongoing; additional cases and recalls are possible.
Anyone who consumed a recalled moringa supplement and developed diarrhea, fever, or stomach cramps should contact a healthcare provider, particularly given the XDR profile of the circulating strains.